1
|
|
2
|
Aboufatima R, Chait A, Dalal A, Zyad A, de Beaurepaire R. No tolerance to the antinociceptive action of calcitonin in rats and mice. Neurosci Lett 2004; 359:5-8. [PMID: 15050698 DOI: 10.1016/j.neulet.2003.09.022] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2003] [Revised: 09/05/2003] [Accepted: 09/09/2003] [Indexed: 11/17/2022]
Abstract
The involvement of a central opioid mechanism in the antinociceptive effect of calcitonin is still a matter of controversy. Since a major characteristic of the effects of opioids is tolerance to repeated treatments, we investigated the effects of acute and chronic (over 7 days) calcitonin injections on pain sensitivity in rats and mice. We examine the effect of single and repeated intraventricular (0.15 UI) and intraperitoneal (2.5, 5 and 20 IU/kg) injection of salmon calcitonin using respectively a tail flick test in rats and the writhing test in mice. The results showed that repeated injection of calcitonin produces a stronger antinociceptive effect than the single injection effect. The antalgic effect, evaluated in the writhing test, is dose-dependent. In both tail-immersion and writhing tests, repeated administration of calcitonin produced a long-lasting antinociceptive effect. These data suggest therefore that the tolerance does not develop after repeated treatment with calcitonin in both rat and mouse. These results support the hypothesis that an important component of the antinociceptive effects of calcitonin is not mediated by an opioid mechanism.
Collapse
Affiliation(s)
- Rachida Aboufatima
- Département de Biologie, Faculté des Sciences Semlalia BP: 2390, 40 000 Marrakech, Morocco
| | | | | | | | | |
Collapse
|
3
|
Goicoechea C, Ormazábal MJ, Abalo R, Alfaro MJ, Martín MI. Calcitonin reverts pertussis toxin blockade of the opioid analgesia in mice. Neurosci Lett 1999; 273:175-8. [PMID: 10515187 DOI: 10.1016/s0304-3940(99)00640-0] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The aim of this paper is to study the influence of salmon calcitonin (SCT) on opioid analgesia when opioid transduction pathways are functionally uncoupled from Gi/o proteins by treatment with pertussis toxin (PTX). The antinociceptive effect of morphine and three selective opioid agonists, [D-Ala2,N-Me-Phe2,Gly5-ol]enkephalin (DAMGO) (OP(3-mu receptor agonist), [D-Pen2.5]-enkephalin (OP-1-delta receptor agonist) and trans-( +/- )-3,4-dichloro-N-methyl-N-[2-1(-pyrrolidinyl)-cyclohexyl]-benzene-acetam ide methane sulfonate (U-50, 488H) (OP1-kappareceptor agonist) was evaluated, using the tail flick test, in mice treated with PTX or with PTX and SCT. PTX blocked the antinociceptive effect of the opioids, being the antinociception similar in control animals and in mice treated with PTX and SCT. Thus, SCT prevents the effect of the blockade of Gi/o-proteins. From this it could be suggested that calcitonin activates alternative antinociceptive mechanisms that are not dependent on Gi/o-proteins.
Collapse
Affiliation(s)
- C Goicoechea
- Departamento de Farmacología, Facultad de Medicina, Universidad Complutense de Madrid, Spain
| | | | | | | | | |
Collapse
|
4
|
Goicoechea C, Ormazábal MJ, Alfaro MJ, Martín MI. Effect of salmon-calcitonin on the analgesic effect of selective mu, delta and kappa opioid agonists in mice. Neurosci Lett 1999; 262:25-8. [PMID: 10076864 DOI: 10.1016/s0304-3940(99)00028-2] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
The analgesic effect of three different opioid agonists, DAMGO ([D-Ala2,N-Me-Phe4,Gly5-ol]enkephalin), U-50,488H (trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidynyl)cyclohexyl] benzene-aceramide methane sulphonate), and [D,Pen2-D,Pen5]-enkephalin, which act upon mu, delta and kappa opioid receptors, respectively, was compared in the presence and absence of salmon-calcitonin (s-CT). The analgesic test used was the writhing test in mice. The analgesic effect of the opioids was significantly enhanced by pretreatment of the animals with s-CT intraperitoneally (i.p.) administered. This effect was more evident for the delta and kappa-agonists. The present result suggests that the joint administration of s-CT and opioids may be a useful and interesting alternative in the treatment of painful diseases resistant to other treatments.
Collapse
MESH Headings
- 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer/administration & dosage
- Analgesics, Non-Narcotic/administration & dosage
- Analgesics, Opioid/administration & dosage
- Analgesics, Opioid/pharmacology
- Animals
- Calcitonin/administration & dosage
- Calcitonin/pharmacology
- Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
- Enkephalin, D-Penicillamine (2,5)-
- Enkephalins/administration & dosage
- Injections, Intraperitoneal
- Injections, Intraventricular
- Male
- Mice
- Receptors, Opioid/agonists
- Receptors, Opioid/metabolism
- Receptors, Opioid, delta/agonists
- Receptors, Opioid, delta/metabolism
- Receptors, Opioid, kappa/agonists
- Receptors, Opioid, kappa/metabolism
- Receptors, Opioid, mu/agonists
- Receptors, Opioid, mu/metabolism
Collapse
Affiliation(s)
- C Goicoechea
- Dpto. Farmacología, Facultad de Medicina, Universidad Complutense de Madrid, Spain
| | | | | | | |
Collapse
|
5
|
Ormazábal MJ, Milanés MV, Martín MI. Serotonergic mechanisms involved in calcitonin potentiation of kappa-opioid receptor-mediated effects on adrenal secretion. Eur J Pharmacol 1997; 340:81-7. [PMID: 9527510 DOI: 10.1016/s0014-2999(97)01355-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Calcitonin can selectively modulate the effects of opioids on the rat hypothalamic-pituitary-adrenal axis and increase the release of corticosterone induced by a kappa-opioid receptor agonist. Considerable evidence supports the involvement of opioid and serotonergic systems in the analgesic effect of calcitonin. In this study, the involvement of hypothalamic serotonergic pathways in the calcitonin potentiation of the effect of (trans-(+/-)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl) cyclohexyl]-benzeneacetamide methane sulphonate (U-50,488H) on the secretion of corticosterone was examined. The correlation between the calcitonin-induced potentiation of the pituitary adrenal response to U-50,488H and changes in serotonin turnover was evaluated. Our results show that the increase in the release of corticosterone induced by treatment with calcitonin + U-50,488H was not evident when the turnover of serotonin was decreased by inhibition of its synthesis with m-hydroxybenzylhydrazine (NSD 1015) or by blockade of its metabolism with trans-2-phenylcyclopropylamine (tranylcypromine). Although other factors can not be discarded, from the present data it can be suggested that the serotonergic system plays an important role in the interaction calcitonin-kappa-opioid receptor agonist in the hypothalamic-pituitary-adrenal axis.
Collapse
Affiliation(s)
- M J Ormazábal
- Departamento de Fisiología y Farmacología, Facultad de Medicina, Universidad de Murcia, Spain
| | | | | |
Collapse
|
6
|
Martin MI, Goicoechea C, Ormazábal MJ, Alfaro MJ. Influence of pertussis toxin on the calcitonin-opioid interaction in isolated tissues. Br J Pharmacol 1996; 119:804-6. [PMID: 8922724 PMCID: PMC1915926 DOI: 10.1111/j.1476-5381.1996.tb15743.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
1. In order to clarify one of the mechanisms involved in the analgesic effect of calcitonin, we have tested the in vitro modifications induced by calcitonin on the effect of opioids. 2. The inhibition of the contractions induced by opioids or clonidine, in guinea-pig ileum or in mouse vas deferens, were significantly reduced in tissues incubated with pertussis toxin (PTX). When tissues were incubated with PTX and calcitonin, the inhibitory effect was restored. 3. These results suggest that calcitonin is able to potentiate a non-PTX-sensitive mechanism of transduction and support the possibility of involvement of similar G-proteins in the effects of opioid and alpha 2-adrenoceptor agonists.
Collapse
Affiliation(s)
- M I Martin
- Departamento de Farmacologia, Facultad de Medicina, U. Complutense, Madrid, Spain
| | | | | | | |
Collapse
|
7
|
Umeno H, Nagasawa T, Yamazaki N, Kuraishi Y. Antinociceptive effects of repeated systemic injections of calcitonin in formalin-induced hyperalgesic rats. Pharmacol Biochem Behav 1996; 55:151-6. [PMID: 8870051 DOI: 10.1016/0091-3057(96)00020-2] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Calcitonin (CT) produces long-lasting analgesia in patients suffering from painful diseases following repeated systemic injections, but there have been only a few contradictory reports on the antinociceptive action of systemic injections of CTs in animal experiments. This study was conducted to elucidate an antinociceptive action of systemic CT in rats. An injection of dilute formalin induced hyperalgesia for about 2 h. Single topical injections of 0.12 and 1.2 U, but not 0.012 U, of [Asu1.7] eel CT (eCT) into the same site of formalin injection inhibited the hyperalgesia. Repeated systemic injections of eCT (4 and 40, but not 0.4, U kg-1 day-1) for 7 days inhibited the hyperalgesia, while the single injection was without effects at doses tested. Although the highest dose of eCT (40 U kg-1 day-1) inhibited an increase in body weight following repeated injections, lower doses (0.4 and 4 U kg-1 day-1) were without effects. The suppression of hyperalgesia following repeated systemic injections of eCT (4 U kg-1 day-1) lasted for at least 24 h, and subsided by 3 days following the last eCT injection. These results indicate that the repeated systemic injections of eCT produce a long-lasting inhibition of formalin-induced hyperalgesia in rats. This inhibitory effect is similar to CT analgesia in human subjects in terms of a necessity for repeated administration, effective dose and long-lasting effects.
Collapse
Affiliation(s)
- H Umeno
- Department of Applied Pharmacology, Research Institute for Wakan-yaku, Toyama Medical and Pharmaceutical University, Japan
| | | | | | | |
Collapse
|
8
|
Martin MI, Goicoechea C, Ormazabal MJ, Alfaro MJ. Effect of the intraperitoneal administration of salmon-calcitonin on the "in vitro" actions of opioid agonists. GENERAL PHARMACOLOGY 1995; 26:1695-9. [PMID: 8745158 DOI: 10.1016/0306-3623(95)00044-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
1. The interaction of intraperitoneal administration of salmon-calcitonin with opioids was studied. The study was carried out using guinea pig ileum (mu and kappa-opioid receptors), rabbit vas deferens (kappa-opioid receptors) and mouse vas deferens (delta-opioid receptors), and selective mu, delta and kappa agonists were used in the pertinent tissues. 2. The treatment with salmon-calcitonin increased, in a dose-dependent manner, the effect of U-50,488H in guinea pig ileum and rabbit vas deferens and the effects of [D-Pen2, D-Pen5] enkephalin in mouse vas deferens. 3. The treatment with analgesic doses of salmon-calcitonin enhances the in vitro effects of kappa- and delta-opioid agonists. The increase of the effectiveness of the opioid agonists may be one of the mechanisms involved on the analgesia induced by salmon-calcitonin.
Collapse
Affiliation(s)
- M I Martin
- Departamento de Farmacologia, Facultad de Medicina, U. Complutense, Madrid, Spain
| | | | | | | |
Collapse
|
9
|
Martin MI, Goicoechea C, Ormazabal MJ, Lopez F, Alfaro MJ. Analgesic effect of two calcitonins and in vitro interaction with opioids. GENERAL PHARMACOLOGY 1995; 26:641-7. [PMID: 7789740 DOI: 10.1016/0306-3623(94)00210-e] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
1. When the analgesic effect of salmon-calcitonin (S-CT) and of eel-calcitonin (E-CT), as well as their influence on the morphine-analgesia were compared, no significant differences were found. 2. While on isolated tissues, E-CT induced a significant increase on the effect of bremazocine, [D-Pen2,D-Pen5]enkephalin and [Met5]enkephalin and no changes were observed on the effect of DAMGO, suggesting that E-CT increases the effects of opioids acting on delta or kappa receptors but not on mu receptors. 3. These findings corroborate the possibility of interactions between calcitonin and the opioid system.
Collapse
Affiliation(s)
- M I Martin
- Departamento de Farmacologia, Facultad de Medicina, U. Complutense, Madrid, Spain
| | | | | | | | | |
Collapse
|
10
|
Milanés MV, Vargas ML, Martín MI. Involvement of kappa-opioid receptor mechanisms in the calcitonin-induced potentiation of opioid effects at the hypothalamus-pituitary-adrenocortical axis. Eur J Pharmacol 1994; 271:103-9. [PMID: 7698193 DOI: 10.1016/0014-2999(94)90270-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
The present study was conducted to evaluate the influence of calcitonin on the neuroendocrine effects of both the mu-opioid receptor agonist, morphine, and the selective kappa-opioid receptor agonist, U-50,488H (trans-3,4-dichloro-N-methyl-N-[2-(1- pyrrolidynyl)cyclohexyl]benzeneacetamide methane sulphonate), at the hypothalamus-pituitary-adrenocortical axis in rats. Calcitonin given alone (2.5, 5 or 10 UI/kg i.p.) induced no changes or a slight reduction (20 UI/kg i.p.) in plasma corticosterone, 45 min after its administration. Morphine did not produce any modification in plasma corticosterone at doses of 3 or 10 mg/kg i.p., whereas it produced a significant increase in corticosterone secretion at doses of 20 or 30 mg/kg i.p., 30 min after its administration. Pretreatment with calcitonin (2.5 UI/kg i.p.) 15 min before morphine (3 or 10 mg/kg i.p.) did not modify the effect of the opioid on plasma corticosterone. U-50,488H (0.5, 1, 5 or 15 mg/kg i.p.) induced an increase in the release of corticosterone only at the higher dose, 30 min after injection. Significantly higher plasma corticosterone levels after U-50,488H administration at doses of 0.5, 1 or 5 mg/kg i.p. were observed when calcitonin was administered 15 min before the kappa-opioid receptor agonist. The enhanced responsiveness of the hypothalamus-pituitary-adrenocortical axis to U-50,488H (1 mg/kg i.p.) in animals pretreated with calcitonin, was completely blocked by the selective kappa-opioid receptor antagonist, nor-binaltorphimine, suggesting a role of kappa-opioid receptors in mediating the calcitonin-induced supersensitivity to U-50,488H.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- M V Milanés
- Department of Physiology and Pharmacology, University School of Medicine, Murcia, Spain
| | | | | |
Collapse
|